Parameter | N | OR for placebo oil | OR for LMF oil | 95% CI |
---|---|---|---|---|
Motor DQa | 391 | 1 | 1.09 | 0.73–1.64 |
Mental DQa | 391 | 1 | 0.97 | 0.65–1.44 |
Subgroup analysis for motor DQb | ||||
 Hemoglobin at 6 months | ||||
  No anemia | 182 | 1 | 1.04 | 0.56–1.95 |
  Mild anemia | 155 | 1 | 1.72 | 0.85–3.50 |
  Moderate anemia | 48 | 1 | 0.64 | 0.15–2.80 |
 Transferrin saturation at 6 months | ||||
  TSAT < 16% | 299 | 1 | 1.09 | 0.68–1.76 |
  TSAT > 16% | 88 | 1 | 1.10 | 0.43–2.83 |
 Vitamin D levels at 6 months | ||||
  Sufficient (≥20 ng/ml) | 202 | 1 | 0.83 | 0.46–1.49 |
  Insufficient (12–20 ng/ml) | 102 | 1 | 3.38 | 1.30–8.82* |
  Inadequate (< 12 ng/ml) | 83 | 1 | 0.66 | 0.24–1.82 |
Analysis for individual clusters of DASIIa | ||||
 Social interaction | 390 | 1 | 1.51 | 1.00–2.29 ** |
 Locomotion: Coordinated movements | 390 | 1 | 1.02 | 0.66–1.58 |
 Language and vocabulary | 390 | 1 | 1.25 | 0.81–1.94 |
 Body control | 390 | 1 | 1.55 | 0.73–3.28 |